Journal of Pediatric Surgery Article Review: January 2022 APSA Issue
With Dr. Gail Bessner & Dr. Charza Jaharifard · hosted by Dr. Rod Gerardo & Dr. Todd Ponsky · StayCurrentMD
Cued at 1:41 · stops at 2:26 · press play
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Podcast
Journal of Pediatric Surgery Article Review: 3rd Quarter (Jul-Sep) 2024
19 min · Published Oct 2024
Video
Quick Literature Updates Ep 22
4 min · Published Oct 2025
Video
Quick Literature Updates Episode 11
Published Jul 2023
Podcast
Gastroschisis and sutureless abdominal wall closure
12 min · Published Jan 2021
Podcast
Journal of Pediatric Surgery Article Review: 2nd Quarter (Apr-Jun) 2024
17 min · Published Sep 2024
Video
Gastroschisis - Clinical Practice Updates
Published Sep 2020
Only a few other public items share this expert — go deeper there →
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026
Video
Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients
1 min · Published May 2026
What the experts said
Historically, surgeons have been incentivized based on work RVUs, which is important for clinical productivity but does not take advantage of other strengths surgeons have.
The concept of academic RVUs was first described approximately 12-13 years ago but did not include how to incentivize people for academic work.
Nationwide Children's Hospital implemented a point-based academic RVU system where people accumulate points based on number of publications, presentations, and other academic pursuits.
The Nationwide system kept work RVUs as part of the incentivization plan along with other goals that must be achievable.
At Akron Children's Hospital under Bob Perry, the bonus structure required the entire group to reach a certain RVU threshold for everyone to receive 50% of their bonus, eliminating competition for cases.
At Saint Justine Hospital, the approach to gastroschisis differed from other institutions in that there was very low use of silos, with pretty much every patient having an attempt at immediate bedside sutureless closure following a protocol developed several years prior.
Before and after protocol implementation at BC Children's Hospital, approximately 75% of gastroschisis patients could be closed immediately, whether in the OR pre-implementation with fascial closure or at bedside post-implementation.
With silo management, parents look at their newborn's intestines through a silo for 5-6 days and cannot hold their baby until the silo is completely reduced.
With immediate closure of gastroschisis, if babies are extubated within 48 hours, parents can hold them within 48 hours, or immediately if managed without intubation.
After implementing the academic RVU system, Nationwide had an increase in presentations, peer-reviewed publications, and external federal research funding.
External federal research funding at Nationwide increased from $750,000 to $5.7 million, representing a 7.7-fold increase.
The BC Children's Hospital gastroschisis study was a retrospective review comparing outcomes before and after implementation of a protocol in 2012, covering patients from 2008 to 2019.
In prior studies of placental mesenchymal stem cells for in utero MMC repair, two surgeries were performed on lambs: one to create the defect and one to repair it, both in utero, with PMSCs used during repair.
In the current study, a single operation was performed at approximately 100 days gestational age where the MMC defect was created and repaired simultaneously, with PMSCs placed directly onto the spinal cord.
The PMSCs did not persist in the placentas, uteri, or lambs at 3 months follow-up.
There was no histological evidence of abnormal growth or tumor development in the ovine model at 3 months.
Human trials using PMSCs for in utero myelomeningocele repair have been initiated with the first two patients enrolled.